Page 10 - SLIDES
P. 10

AURA











             • Randomize phase II trial
                (n=56) - INTERIM RESULTS


             • Neoadjuvant trial


                    • GC + avelumab vs
                       ddMVAC + avelumab


             • Primary outcome: pCR
   5   6   7   8   9   10   11   12   13   14   15